Amino Acids compound antibody & antigen (hapten) for immunoassay and unique Amino Acids deficiency tests

Amino acids are vital biological molecules in the context of the structure and function of cells and tissues; they are the precursors to protein and peptides. Particular amino acids has been identified and this has facilitated the invention of numerous diagnosis and treatment procedures. South Korea’s GeneMedi has produced anti-small molecule antibodies and small molecule competitive antigens which have proven to be very specific and efficient in recognizing and binding to amino acids, as well as controlling their influence on human health in regards to aminos acids diagnostics and therapeutics.

Depending on their role in the human body, amino acids can be divided into essential and non-essential, branched-chain amino acids (BCAAs) and others. Some of the amino acids cannot be synthesized in the human body and have to be taken as foods or supplements. Such molecules as small molecules antibodies and small molecule competitive antigens of GeneMedi are suitable for the development of diagnostic assay and treatments for diseases resulting from absence of vital amino acids by quantifying relevant amino acids, enzyme inhibitors. Conditional amino acids are these that the body can produce on its own and therefore one is not obliged to take them through diet or in the form of supplements. GeneMedi’s product involves the identification of non-essential amino acid content and comparative measures, which is important in designing diagnostic tests and therapies such as receptor agonists, for the prevention and management of diseases due to imbalances in amino acids. BCAAs are involved in proteins biosynthesis and muscle tissue catabolism and has recently attracted a lot of interest due to its possible use as independent nutrient for improving nitrogen balance. Thus, GeneMedi’s product allows creating diagnostic and therapeutic assays to monitor and prevent the diseases associated with BCAAs; creating muscle building supplements based on BCAAs with accurate doses and creating metabolic modulators for appropriate types of diseases.

There is large possibility in the application of GeneMedi’s wholesale anti-small molecule antibodies and small molecule competitive antigens in the amino acid diagnostic field and the therapeutic field. Classification of amino acids and identification of individual components have prospects for individualized medicine and effective treatment, based on the improvement of patient’s condition and life quality. Concerning the application of GeneMedi’s antigen and antibody technology, the methods include ELISA, LFIA, colloidal gold immunochromatographic assay, chemiluminescent immunoassay (CLIA), turbidimetric inhibition immunoassay (TINIA), Immunonephelometry and POCT for detecting the small molecules of amino acids from the various sample types.